Accessibility Menu
iShares Trust - iShares U.s. Pharmaceuticals ETF logo

iShares Trust - iShares U.s. Pharmaceuticals ETF(NYSEMKT) IHE

Current Price$102.40
Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)+724%
5 Year+75%
1 Year+50%
1 Month+8%
iShares Trust - iShares U.s. Pharmaceuticals ETF last closing stock price
MetricPriceDate
Last closeUSD 102.382026-07-24
iShares Trust - iShares U.s. Pharmaceuticals ETF stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.45%USD 100.922026-07-17
1 month+7.68%USD 95.082026-06-24
3 month+19.38%USD 85.762026-04-24
Year to date+21.45%USD 84.302025-12-31
1 year+50.46%USD 68.042025-07-24
3 year+77.21%USD 57.772023-07-25
5 year+75.46%USD 58.352021-07-23
Since inception+723.7%USD 12.432006-05-05

iShares Trust - iShares U.s. Pharmaceuticals ETF Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$1.47

Beta (Volatility)

0.53 (Low)

Price

$102.40

Volume

637

Open

$102.53

Previous Close

$102.40

Daily Range

$102.04 - $102.59

52-Week Range

$64.94 - $103.70

Estimated Earnings Date

N/A

IHE News

ETFvsETF-Blue.png

Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?

Brendan CoffeyJul 22, 2026
ETFvsETF-Green.png

IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?

Andy GouldJul 19, 2026
ETFvsETF-Red.png

IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?

Cory RenauerJul 18, 2026
ETFvsETF-Purple.png

Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH?

Robert IzquierdoJul 16, 2026
ETFvsETF-Red.png

IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?

Andy GouldJul 10, 2026
ETFvsETF-Purple.png

IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?

Andy GouldJul 5, 2026
ETFvsETF-Green.png

Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?

Josh Kohn-LindquistJun 17, 2026
ETFvsETF-Blue.png

iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns

Brendan CoffeyJun 10, 2026
Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About iShares Trust - iShares U.s. Pharmaceuticals ETF

The iShares U.S. Pharmaceuticals ETF aims to replicate the investment performance of a benchmark index composed of U.S. pharmaceutical companies. This ETF provides investors with exposure to a diverse range of equity securities within the pharmaceutical sector.

Products and Services
  • Investment in U.S. pharmaceutical companies
  • Replicates performance of a benchmark index
  • Offers diversification within the healthcare sector
Growth Outlook
  • Market capitalization of approximately $782 million indicates strong investor interest
  • Dividend yield of 1.45% provides income potential for investors
  • Stock price range of $64.94 to $103.7 shows significant growth potential
Financial Highlights
  • Recent stock price of $100.92 reflects solid market performance
  • Trailing twelve months dividend per share of $1.46692
  • Average trading volume of 170,433 shares indicates active investor engagement
The iShares U.S. Pharmaceuticals ETF offers a strategic investment opportunity for those looking to gain exposure to the pharmaceutical industry. With a focus on replicating the performance of a benchmark index, this ETF allows investors to diversify their portfolios while benefiting from the growth potential of U.S. pharmaceutical companies. The recent stock price and dividend yield highlight the ETF's appeal, making it a noteworthy option for investors interested in the healthcare sector.
AI Generated • Jul 19, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

San Francisco, CA 94105, US

IHE Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

1.43%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

14.40M

Volume

637

Avg. Volume

200.40K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

iShares Trust - iShares U.s. Pharmaceuticals ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PPHVanEck Pharmaceutical ETF
$110.63+0.62%
INDYiShares India 50 ETF
$42.38+0.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
FFord Motor Company
$14.37+0.02%

Questions About IHE

What is the current price of iShares Trust - iShares U.s. Pharmaceuticals ETF?

iShares Trust - iShares U.s. Pharmaceuticals ETF is trading at $102.40 per share.

What is the 52-week range for iShares Trust - iShares U.s. Pharmaceuticals ETF?

Over the past 52 weeks, iShares Trust - iShares U.s. Pharmaceuticals ETF has traded between $64.94 and $103.70.

How much debt does iShares Trust - iShares U.s. Pharmaceuticals ETF have?

iShares Trust - iShares U.s. Pharmaceuticals ETF total debt is unavailable.

How much cash does iShares Trust - iShares U.s. Pharmaceuticals ETF have on hand?

iShares Trust - iShares U.s. Pharmaceuticals ETF does not have cash on hand data available.

What is iShares Trust - iShares U.s. Pharmaceuticals ETF’s dividend yield?

iShares Trust - iShares U.s. Pharmaceuticals ETF currently has a dividend yield of 1.43%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services